All filters
Slidesets
01 Peter W Hunt_Mechanisms of Poor Immune Reconstitution in HIV Patients
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Slidesets
03 Antonella Castagna_CD4 responses in trials of highly treatment experienced pa
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Slidesets
Walther Mothes - Potential role of specific drugs in immune reconstitution
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Videos
Walther Mothes | Potential Role of Specific Drugs in Immune Reconstitution
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Videos
Peter Hunt | Mechanisms of Poor Immune Reconstitution in HIV Patients
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Videos
Antonella Castagna | CD4 Responses in Trials of Highly Treatment-Experienced Patients
Presented at:
Immune Non-Responders - A Remaining Unmet Need | Satellite Symposium at EACS 2021
Slidesets
Behrens, Georg - Clinical case #1
Slidesets
Dr. Altfeld - INR EACS 2021 10.10
Slidesets
DDI_HTA_EACS11ott2021 Andrea Calcagno
Slidesets
Behrens, Georg - Clinical case #1
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Cliona Ni Cheallaigh | Clinical Case #2: Patient with Immune Non-Response
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Dr. Marcus Altfeld | Immune Non-Responders - A Remaining Unmet Need
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Dr. Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment Options
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Anna Maria Geretti | Epidemiology of Patients with Limited Treatment Options in Europe
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Slidesets
Andrea Calcagno | Pharmacological Considerations in Optimizing Care for Patients with Limited Treatment Options
Presented at:
Managing HIV Patients With Limited Treatment Options 2021
Videos
A Phase 3, Open-label, Dose Escalation study to determine the pharmacokinetics of Atazanavir administered with RIfampicin to HIV positive adults on sEcond-line ART regimen with suppressed HIV-1 viral load (DERIVE): Scheduled Interim Analysis
Presenter: Sandra Grañana Castillo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Drug-Drug Interactions in Hospitalized COVID-19 Patients Receiving Investigational Drugs (CATCO-DDI)
Presenter: Nancy Sheehan
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Videos
Low-level viremia is associated with lower cumulative adherence to antiretroviral therapy in persons with HIV
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Using PBPK modelling to estimate lamivudine exposure in children with abnormal kidney function
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
Charles Boucher Memorial Lecture
Antiviral PK 2021 Charles Boucher Memorial Lecture Day 3 | 22 September Title: Tribute to Charles Boucher's Contributions to this Program and HIV Research Presenter: Jonathan Schapiro
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021
Videos
John Gerber Memorial Lecture
Antiviral PK 2021 Session: John Gerber Memorial Lecture Day 1 | 20 September Presenter: David Back
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021